Dublin launches formal talks with pharma industry on new drug pricing framework

The Irish government has initiated formal negotiations with the pharmaceutical industry to establish a new multi-year agreement on the supply and pricing of medicines, aiming to strike a balance between fiscal discipline and enhanced patient...

EU Commission raids pharma company over suspected antitrust violations

The European Commission announced on Tuesday that it had conducted unannounced inspections at the premises of a pharmaceutical company suspected of violating EU antitrust rules. When asked about the matter, a European Commission source told...

Iran’s pharma industry charts a path to global partnership

In the heart of Tehran, beneath the vaulted ceilings of the Imam Khomeini Mosalla, the 10th Iran Pharma International Exhibition unfolded with little fanfare outside the region. But for those paying attention to the shifting dynamics of Iran’s...

Trump drug tariff draws backlash from NJ pharma industry

The basics: Trump plans 100% tariff on branded drugs imported to U.S. BioNJ, HINJ warn of risks to patients, jobs & innovation Major pharma firms investing billions in U.S. production sites Industry groups urge exemptions to protect drug supply...

Denmark Healthcare Industry Market Databook 2025 | 300+ KPIs Covering Healthcare Infrastructure, Patient Demographics, Diagnostics, Public and Private Spending, Clinical and Non-Clinical Workforce - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Sep 29, 2025-- The "Denmark Healthcare Industry Market Size & Forecast by Value and Volume Across 300+ KPIs Covering Healthcare Infrastructure, Patient Demographics, Diagnostics, Public and Private Spending, Clinical and...

Syngene scales novel cardiovascular API from lab synthesis to tox-batch manufacturing for a pharma company

Syngene had successfully demonstrated the small-scale synthesis of a novel vascular calcification inhibitor API from lab-scale to tox-batch manufacturing. This was following the request of a pharma company (name withheld) that requested a...

Emma Walmsley steps down as CEO of GSK as pharmaceutical industry faces upheaval

Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our...

Pfizer Announces Agreement with Trump Administration to Lower Prices, Join TrumpRx, and Avoid Tariffs

Update: Pfizer leadership officially announced an agreement with the Trump administration to reduce drug prices as per the directives detailed in the President’s MFN executive order.2 In a statement on its website, Pfizer stated that the agreement...

Pfizer’s obesity bet shows 14.1% weight loss in Phase IIb trial

Pfizer’s $4.9bn bet on obesity startup Metsera is looking promising, with 14.1% weight loss reported in a Phase IIb trial. In the VESPER-1 trial (NCT06712836), MET-097i, a glucagon-like peptide-1 receptor agonist (GLP-1RA), demonstrated mean...

S Korea becomes top buyer of Turkish pharmaceutical industry

ANKARA Türkiye’s pharmaceutical exports reached a total of $9.12 billion over the past five years, with South Korea emerging as the leading destination at $2.18 billion, according to data from the Turkish Statistical Institute (TÜİK). Annual...

<![CDATA[Resourcing and Outsourcing Trends in Drug Development]]>

In June and July 2025, I interviewed 25 individuals in the biopharmaceutical community who either manage teams and vendors or have had influence on resourcing and outsourcing decisions. These included CEOs, CSOs, vice presidents of clinical...

UK trade secretary takes dig at pharma sector amid crunch price talks

The prime minister’s business adviser, Varun Chandra, flew to Washington this week to discuss tariffs. In parallel, the U.K. government is locked in talks with companies over NHS drug pricing, with Science Minister Patrick Vallance recently...

Advancing the pharma value chain

Gunter van Hoof, VP of global clinical trial distribution, Marken highlights the challenges of storage, supply and distribution in an evolving world. The pharmaceutical supply chain has always been complex, but today’s environment introduces new...

The Psychiatric Pipeline in Review: Quarter 3, 2025

The third quarter of 2025 saw some huge successes and fails in the psychiatric treatment pipeline. Here, learn more about what percentage of that news was positive vs negative, what disease states were most prominently featured, and what...

<![CDATA[Dermatology Times September 2025 Recap]]>

Clearances, Approvals, Updates, and Recommendations Biofrontera Completes Ameluz Phase 2b Trial for Moderate to Severe Acne Biofrontera Inc. advances acne treatment with aminolevulinic acid hydrochloride gel, completing a phase 2b study for...

Trump, Pfizer drug pricing deal short on details, possible impact

Dive Brief: Pfizer on Tuesday signed a deal with the Trump administration to offer “most favored nation” drug prices to every state Medicaid program and discounted prices directly to other consumers through a new website. The agreement also...

Pharmaceutical Executive Daily: TrumpRx Revealed

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Pharmaceutical Executive Daily, we cover AbbVie’s new API manufacturing site in Illinois,...

UC San Diego: Student Support, Academic Rigor, and Extensive Real-World Clinical Experience

We are continuing our new series, Media Day, where we spotlight individual medical institutions and infectious disease (ID) programs. Today, we spotlight UC San Diego’s Skaggs School of Pharmacy and Pharmaceutical Sciences and the university’s...

Gilead signs $34.5M deal for Hanmi/HHP’s I.V.-to-oral drug tech

Hanmi Pharmaceutical Co. Ltd. and Health Hope Pharma Ltd. may be getting a second wind for encequidar and the Orascovery platform, with Gilead Sciences Inc. picking up exclusive global rights to develop and commercialize encequidar in the field of...

Bayer seeks approval for key heart drug in India

San Sebastian (Spain): Pharmaceutical major Bayer has filed for approval to market its patented drug finerenone in India for treating certain heart failure patients, a potential boost in a country increasingly grappling with early onset of heart...